Direct treatment costs of HIV/AIDS in Portugal

Revista de Saude Publica

Volumn 47, Issue 5, 2013, Pages 865-872

  Perelman, Julian ^a   Alves, Joana ^a   Miranda, Ana Cláudia ^b   Mateus, Céu ^a   Mansinho, Kamal ^b   Antunes, Francisco ^c   Oliveira, Joaquim ^d   Poças, José ^e   Doroana, Manuela ^c   Marques, Rui ^f   Teófilo, Eugénio ^g   Pereira, João ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b HOSPITAL EGAS MONIZ   (Portugal)

^c HOSPITAL DE SANTA MARIA   (Portugal)

^d CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^e Centro Hospitalar de Setubal   (Portugal)

^f HOSPITAL DE SÃO JOÃO   (Portugal)

^g HOSPITAL DOS CAPUCHOS   (Portugal)

Author keywords

Acquired immunodeficiency syndrome; Anti hIV agents; Economics; Health care costs; Medical

Indexed keywords

ADULT; AGED; ARTICLE; ECONOMICS; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MIDDLE AGED; PORTUGAL; RETROSPECTIVE STUDY; STATISTICS;

ADULT; AGED; FEMALE; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PORTUGAL; RETROSPECTIVE STUDIES;

EID: 84893181097     PISSN: 00348910     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0034-8910.2013047004598     Document Type: Article

References (14)

1. Chen RY, Accortt NA, Westfall AO, Mugavero MJ, Raper JL, Cloud GA, et al. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis. 2006;42(7):1003-10. DOI:10.1086/500453
2. Hutchinson AB, Farnham PG, Dean HD, Ekwueme DU, Rio C del, Kamimoto L, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. J Acquir Immune Defic Syndr. 2006;43(4):451-7. DOI:10.1097/01.qai.0000243090.32866.4e
3. Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, et al. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011;343:d6884. DOI:10.1136/bmj.d6884
4. Krentz HB, Gill MJ. Cost of medical care for HIVinfected patients within a regional population from 1997 to 2006. HIV Med. 2008;9(9):721-30. DOI:10.1111/j.1468-1293.2008.00613.x
5. Levy AR, James D, Johnston KM, Hogg RS, Harrigaan BP, Soboley B, et al. The direct costs of HIV/ AIDS care. Lancet Infect Dis. 2006;6(3):171-7. DOI:10.1016/S1473-3099(06)70413-3
6. Lowy A, Page J, Jaccard R, Ledergerber B, Somaini B, Weber R, et al. Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care: a prospective cohort study. AIDS Care. 2005;17(6):698-710. DOI:10.1080/09540120412331336689
7. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461-94. DOI:10.1016/S0167-6296(01)00086-8
8. Manning WG. Dealing with skewed data on costs and expenditures. In: Jones AM, editor. The Elgar companion to health economics. Cheltenham: Edward Elgar Publishing; 2006. p.439-46.
9. Mostardt S, Hanhoff N, Wasem J, Goetzenich A, Schewe K, Wolf E, et al. Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGNÄ K3A Study. Eur J Health Econ. 2013;14(5):799-808. DOI:10.1007/s10198-012-0425-4
10. Paltiel AD, Weinstein MC, Kimmel AD, Seage GR 3rd, Losina E, Zhang H, et al. Expanded screening for HIV in the United States: an analysis of costeffectiveness. N Engl J Med. 2005;352(6):586-95. DOI:10.1056/NEJMsa042088
11. Paltiel AD, Freedberg KA, Scott CA, Schackman BR, Losina E, Wang B, et al. HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness. Clin Infect Dis. 2009;48(6):806-15. DOI:10.1086/597095
12. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care. 2006;44(11):990-7. DOI:10.1097/01.mlr.0000228021.89490.2a
13. Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, et al. Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults. AIDS. 2012;26(1):45-56. DOI:10.1097/QAD.0b013e32834dce6e
14. Tramarin A, Campostrini S, Postma MJ, Calleri G, Tolley K, Parise N, et al. A multicentre study of patient survival, disability, quality of life and cost of care: among patients with AIDS in northern Italy. Pharmacoeconomics. 2004;22(1):43-53. DOI:10.2165/00019053-200422010-00004